Status | Study |
Recruiting |
Study Name: Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Condition: Rare Disorders Undiagnosed Disorders Disorders of Unknown Date: 2013-02-13 |
Completed |
Study Name: Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients Condition: Ataxia Telangiectasia Date: 2010-02-24 Interventions: Biological: Prevenar® (7-valent pneumococcal conjugate vaccine) |
Recruiting |
Study Name: Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT) Condition: Ataxia Telangiectasia Growth Failure Date: 2010-01-19 Interventions: Drug: Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate 1 mg Estradiol valerate with fo |
Recruiting |
Study Name: The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied Longitudinally Condition: Ataxia Telangiectasia Date: 2009-08-02 |
Completed |
Study Name: Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia Condition: Ataxia Chorea Dystonia P Date: 2009-07-30 Interventions: Drug: amantadine sulphate amantadine 5/mg/kg for 2 month- tapered up during 2 weeks at 1 month possibili |
Recruiting |
Study Name: Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases Condition: Neurodegenerative Disorders Date: 2009-04-02 |
Completed |
Study Name: Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT) Condition: Ataxia Telangiectasia (AT) Date: 2008-04-07 Interventions: Drug: Conjugated pneumococcal vaccine (Prevenar) Other Name: Prevenar |
Recruiting |
Study Name: Baclofen Treatment of Ataxia Telangiectasia Condition: Ataxia Telangiectasia Date: 2008-03-14 Interventions: Drug: Baclofen Drug given by o |
Completed |
Study Name: Study for Treatment of Cancer in Children With Ataxia-telangiectasia Condition: Ataxia-Telangiectasia Date: 2005-09-12 Interventions: Drug: vinblastine, vincristine, prednisone, daunorubicin |
Completed |
Study Name: Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Condition: Cancer Date: 2005-05-03 Interventions: Drug: caspofungin acetate |